Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04877990
What this trial is testing

Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Bristol-Myers Squibb 67
Testing effectiveness (Phase 2)UnknownNCT04583358
What this trial is testing

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Who this might be right for
Ulcerative Colitis
Applied Molecular Transport 105
Testing effectiveness (Phase 2)Study completedNCT02389790
What this trial is testing

Extension Study of MT-1303 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 46
Not applicableActive Not RecruitingNCT02808780
What this trial is testing

An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Janssen Biotech, Inc. 535
Not applicableLooking for participantsNCT07302360
What this trial is testing

A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Xian-Janssen Pharmaceutical Ltd. 200
Very early researchNot Yet RecruitingNCT07309744
What this trial is testing

Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease

Who this might be right for
Moderate-to-severe Ulcerative ColitisCrohn's Disease (CD)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03519945
What this trial is testing

Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,058
Large-scale testing (Phase 3)Ended earlyNCT05644665
What this trial is testing

Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 131
Testing effectiveness (Phase 2)Active Not RecruitingNCT06029972
What this trial is testing

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 176
Not applicableUnknownNCT05262829
What this trial is testing

Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease

Who this might be right for
Crohn Disease
Shanghai East Hospital 40
Large-scale testing (Phase 3)Study completedNCT00105300
What this trial is testing

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 300
Not applicableActive Not RecruitingNCT01848561
What this trial is testing

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 8,250
Large-scale testing (Phase 3)Ended earlyNCT04173273
What this trial is testing

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Pfizer 379
Not applicableLooking for participantsNCT05456893
What this trial is testing

Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies

Who this might be right for
Ulcerative ColitisInflammatory Bowel Diseases
Central Hospital, Nancy, France 95
Large-scale testing (Phase 3)Study completedNCT00853099
What this trial is testing

Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie (prior sponsor, Abbott) 274
Testing effectiveness (Phase 2)Looking for participantsNCT06979336
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 224
Testing effectiveness (Phase 2)Looking for participantsNCT07080034
What this trial is testing

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Biocad 198
Testing effectiveness (Phase 2)Ended earlyNCT03616821
What this trial is testing

Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisIBD
AstraZeneca 242
Large-scale testing (Phase 3)Looking for participantsNCT06865417
What this trial is testing

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Alfasigma S.p.A. 80
Testing effectiveness (Phase 2)Study completedNCT03854305
What this trial is testing

Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Provention Bio, Inc. 93
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation